Literature DB >> 16444817

Synthesis and absorption of intestinal microbial lysine in humans and non-ruminant animals and impact on human estimated average requirement of dietary lysine.

Cornelia C Metges1, Markus Eberhard, Klaus J Petzke.   

Abstract

PURPOSE OF REVIEW: While there are reports on the nature of synthesis and absorption of intestinal microbial lysine in humans and non-ruminant animals, there are few efforts to quantify microbial amino acid absorption in human subjects. We review the available information on the synthesis of microbial lysine and the quantification of its absorption and utilization by the human host and monogastric model animals. In addition, we explore the impact of microbial lysine on the current estimated average requirement of dietary lysine. RECENT
FINDINGS: It is still uncertain whether microbial amino acids are absorbed primarily from the small or the large intestine in humans. In the pig, the majority of microbial lysine is absorbed in the small intestine. It appears that microbial lysine contribution is responsive to the nutritional status of the host. Estimates for microbial lysine contribution in adult humans on adequate or low protein diets range from 12 to 68 mg/kg per day. It is unlikely that these estimates represent net values because of methodological concerns related to the 15N tracer methodology used.
SUMMARY: We conclude that microbial lysine contributes to the lysine homeostasis in humans and other non-ruminant mammals. Microbial lysine utilization by the host is a continuous process and occurs both with low, adequate, and high protein intakes, and under protein-free and low lysine dietary conditions in growing and adult individuals. We also conclude that the estimated average lysine requirement for humans already considers lysine contributed by the intestinal microbiota.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16444817     DOI: 10.1097/01.mco.0000196142.72985.d3

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  5 in total

1.  Modulation of the gut microbiota with antibiotic treatment suppresses whole body urea production in neonatal pigs.

Authors:  Patrycja Puiman; Barbara Stoll; Lars Mølbak; Adrianus de Bruijn; Henk Schierbeek; Mette Boye; Günther Boehm; Ingrid Renes; Johannes van Goudoever; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-08       Impact factor: 4.052

2.  Donor-dependent fecal microbiota transplantation efficacy against necrotizing enterocolitis in preterm pigs.

Authors:  Yan Hui; Gisle Vestergaard; Ling Deng; Witold Piotr Kot; Thomas Thymann; Anders Brunse; Dennis Sandris Nielsen
Journal:  NPJ Biofilms Microbiomes       Date:  2022-06-09       Impact factor: 8.462

3.  Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.

Authors:  Zoltan Pataky; Laurence Genton; Laurent Spahr; Vladimir Lazarevic; Sylvain Terraz; Nadia Gaïa; Laura Rubbia-Brandt; Alain Golay; Jacques Schrenzel; Claude Pichard
Journal:  Dig Dis Sci       Date:  2016-05-03       Impact factor: 3.199

4.  Small Intestinal Absorption of Methylsulfonylmethane (MSM) and Accumulation of the Sulfur Moiety in Selected Tissues of Mice.

Authors:  Thomas Wong; Richard J Bloomer; Rodney L Benjamin; Randal K Buddington
Journal:  Nutrients       Date:  2017-12-25       Impact factor: 5.717

5.  Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model.

Authors:  Francois-Pierre J Martin; Yulan Wang; Norbert Sprenger; Ivan K S Yap; Torbjörn Lundstedt; Per Lek; Serge Rezzi; Ziad Ramadan; Peter van Bladeren; Laurent B Fay; Sunil Kochhar; John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2008-01-15       Impact factor: 11.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.